"Sevelamer" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A polymeric amine that binds phosphate and is used to treat HYPERPHOSPHATEMIA in patients with kidney disease.
| Descriptor ID |
D000069603
|
| MeSH Number(s) |
D02.092.782.634
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sevelamer".
Below are MeSH descriptors whose meaning is more specific than "Sevelamer".
This graph shows the total number of publications written about "Sevelamer" by people in this website by year, and whether "Sevelamer" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sevelamer" by people in Profiles.
-
Efficacy and safety of sevelamer carbonate in hyperphosphatemic pediatric patients with chronic kidney disease. Pediatr Nephrol. 2018 02; 33(2):325-333.
-
Phosphate Binders: The Evidence Gap Persists. Am J Kidney Dis. 2016 11; 68(5):667-670.
-
The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. Am J Kidney Dis. 2015 Sep; 66(3):479-88.
-
Trends in the incidence of intestinal perforation in US dialysis patients (1992-2005). J Nephrol. 2013 Mar-Apr; 26(2):281-8.
-
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD006023.
-
A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis. Am J Kidney Dis. 2010 Feb; 55(2):307-15.
-
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. Am J Kidney Dis. 2009 Oct; 54(4):619-37.
-
Phosphate binder choice in dialysis patients: a call for evidence-based rather than marketing-based clinical practice. Am J Kidney Dis. 2008 Mar; 51(3):362-5.
-
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial. J Ren Nutr. 2008 Jan; 18(1):91-8.
-
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007 Nov; 72(9):1130-7.